Skip to main content

Month: June 2025

AVTL to develop ammonia terminal in Pipavav

AVTL to develop ammonia terminal in Pipavav Rotterdam, the Netherlands, 20 June 2025 In India, AVTL, will develop a brownfield ammonia terminal at the existing Pipavav location. The terminal will be the first independent ammonia storage terminal in India.  The terminal will facilitate ammonia imports, serving the extensive fertilizer market. Next to the usage in the fertilizer industry, ammonia is a key carrier for hydrogen and identified as an important product in the energy transition. The terminal will support green ammonia exports in the future, this ties in with the strategy to accelerate towards infrastructure for the energy transition. The terminal is designed as a third-party, independent storage facility with a storage capacity of around 36,000 metric tons and is expected to be commissioned by the end of 2026. Its customers...

Continue reading

Carbios presents the results of its Annual General Meeting of 19 June 2025 and the composition of its Board of Directors

Clermont-Ferrand (France), June 20, 2025 (6:45 am CEST). CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces the results of its Ordinary and Extraordinary general Meeting of June 19, 2025. Shareholders physically present, represented or voting by post totalled 31.18% of the shares composing the Company’s share capital and carrying voting rights, and 31.25% of the voting rights. All the resolutions on the agenda were approved, excepted the 21st Resolution. It has notably been approved the renewal of the term of office of Business Opportunities for L’Oréal Development (BOLD), Michelin Ventures, Ms Isabelle Parize, Mr Vincent Kamel, Ms Karine Auclair and Mr Mateus Schreiner Garcez Lopes as directors. The...

Continue reading

IDEX Biometrics ASA: Mandatory notification of trades – 19 June 2025

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15 June 2025 regarding the share issue to personnel. The subscription and allocation have been completed on 19 June 2025. IDEX Biometrics ASA informs of primary insider transactions as listed in the attached notifications. For further information contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@idexbiometrics.com About this notice: This notice was issued by Kristian Flaten, CFO, on 20 June 2025 at 04:00 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and Section 5-12 of the Norwegian Securities Trading Act.Attachments2025-06-19 Annika Olsson notice2025-06-19 Morten Opstad notice2025-06-19 K Konsult...

Continue reading

Mandatory notice of shareholding 19 June 2025 – II

IDEX Biometrics ASA (“IDEX”) discloses the following on behalf of a shareholder. Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15 June 2025 regarding the share issue to personnel, and the notice regarding mandatory notification of trades on 20 June 2025. The subscription and allocation have been completed on 19 June 2025. Anders Storbråten, including associated company Pinchcliffe AS, will hold 975,635,000 shares in IDEX. Following registration of the share capital increase for the personnel placement, the ownership will represent 20.62 % of the shares and voting rights in IDEX. About this notice: This notice was issued by Kristian Flaten, CFO, on 20 June 2025 at 04:22 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA)...

Continue reading

Mandatory notice of shareholding 19 June 2025

IDEX Biometrics ASA (“IDEX”) discloses the following on behalf of a shareholder. Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15 June 2025 regarding the share issue to personnel. The subscription and allocation have been completed on 19 June 2025. Sundt AS holds 230,491,498 shares in IDEX. This is unchanged from the previous notice on 14 April 2025. Following registration of the share capital increase for the personnel placement, the ownership will represent 4.87 % of the shares and voting rights in IDEX. About this notice: This notice was issued by Kristian Flaten, CFO, on 20 June 2025 at 04:15 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

Continue reading

Prime Announces Voting Results of 2025 AGM

VANCOUVER, British Columbia, June 19, 2025 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announces that shareholder voting at the Company’s Annual General and Special Meeting of shareholders held on June 19, 2025 (the “Meeting”) has resulted in the election of all the directors listed as nominees in management’s information circular dated May 5, 2025 (the “Circular”), as well as the approval of all matters presented. Summaries of the results of voting are provided below. Prime is focused on the exploration and development of its wholly owned Los Reyes gold-silver project in Sinaloa State, Mexico (“Los Reyes” or the “Project”). Recent highlights include:Announcement that the Company is targeting the delivery of a Preliminary Economic Assessment (“PEA”)...

Continue reading

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24. Presentation highlights include the ProstACT Global Phase 3 study of TLX591 in advanced prostate cancer, preclinical data on Telix’s TLX252 alpha therapy candidate in CAIX1 -expressing tumors in combination with DDRIs2, and clinical study data on Illuccix® impact on decision-making. Two sponsored symposia will highlight innovation in precision diagnostics, the first on CAIX-PET3 imaging in renal...

Continue reading

Cygnus raises $18.3m to accelerate resource growth and mining studies

The raising follows outstanding drilling results at the flagship Corner Bay deposit and Golden Eye prospect, which both offer substantial upside TORONTO and PERTH, Australia, June 19, 2025 (GLOBE NEWSWIRE) — HighlightsCygnus has received firm commitments totalling A$18.3m via a share placement to institutional and sophisticated investors The Placement was priced at A$0.086 per share, being an 8.5% discount to the last sale price of A$0.094 The Placement was extremely well-supported with strong demand from existing and new investors, particularly North American investors, resulting in applications being scaled back The Placement will be split into two tranches:Tranche 1 – unconditional tranche to raise approximately A$18.2m; and Tranche 2 – A$0.1m tranche to a director, subject to shareholder approvalFollowing a highly successful...

Continue reading

Belo Sun Announces Planned Executive Leadership Transition

TORONTO, June 19, 2025 (GLOBE NEWSWIRE) — Belo Sun Mining Corp. (“Belo Sun” or the “Company” (TSX: BSX, OTCRB: BSXGF) announces that Ms. Ayesha Hira will step down as Interim President & CEO on July 4, 2025. Ms. Hira will remain in place as the Company makes a planned transition to its new leadership team, which Belo Sun intends to announce in the coming days. Ms. Hira has also decided not to stand for re-election as a director of the Company at the upcoming shareholder meeting. The Board would like to thank Ms. Hira for her dedication and hard work both in her role as the Interim President & CEO and as a member of the Board. Executive Chairman, Mr. Mark Eaton said, “The Company is grateful for Ayesha’s diligence and stewardship over the past 14 months. Under her leadership, the Company has reignited and strengthened...

Continue reading

Dundee Corporation Announces Voting Results from 2025 Annual Meeting of Shareholders

TORONTO, June 19, 2025 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (“Dundee” or the “Corporation”) is pleased to announce the voting results from its Annual Meeting of Shareholders (the “Meeting”) which was held earlier today. Shareholders voted in favour of all items of business before the Meeting, as follows: Appointment of Auditor PricewaterhouseCoopers LLP were appointed as Auditor of the Corporation and the directors of the Corporation were authorized to fix the remuneration of the Auditor. Details of the voting results are set out below:  Total Votes % of Votes Cast  Votes in Favour 354,684,508 99.94  Votes Withheld 204,353 0.06  Total Votes Cast 354,888,861 100         Election of Directors The shareholders elected each of the seven nominees listed in the Corporation’s Management Proxy Circular. Details...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.